Point of Care Diagnostics Market by Product Type (Infectious Disease Testing Kits, Cancer/Tumour Markers Testing, Cardio-Metabolic Monitoring Kits, Fertility and Pregnancy Testing Kits, Haematological Testing Kits, Faecal Occult Testing Kits, Glucose Monitoring Kits, Cholesterol Test Strips, Urinalysis Testing Kits, Others), by Prescription Mode (Over-the-counter (OTC) Testing Kits, Prescription-based Testing Kits), by End User (Hospitals, Diagnostic Centres, Homecare, Others) and Geography

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Point-Of-Care Diagnostics Market size was valued at USD 40,918.2 million in 2022 and is projected to grow at a 6.9% CAGR from 2023 to 2029. Point-of-care (POC) diagnostics are medical devices that provide immediate results in the investigation (diagnosis and monitoring) of various diseases such as diabetes, cancer, cardiac disease, and others. Based on the product, the global diagnostics market is segmented into Infectious Disease Testing Kits, Cardio-Metabolic Monitoring Kits, COVID-19 Testing Kits, Haematological Testing Kits, Faecal Occult Testing Kits, Glucose Monitoring Kits, Cholesterol Test Strips, Urinalysis Testing Kits, Others. The Glucose Monitoring Kits segment is anticipated to grow at a significant CAGR over the forecast years, Due to increased sales of diabetes rapid diagnostics kits. These are available without a prescription over the counter and assist patients in self-testing and monitoring their glucose levels. Because the kits are widely available, they are highly preferred, increasing product sales. EKF Diagnostics, for example, announced the launch of STAT-Site WB to manage diabetes in May 2020. The test produces results in 10 minutes and is intended for use at point-of-care diagnostics such as doctor's offices, diagnostic laboratories, and clinics. The rising prevalence of chronic and infectious diseases and a growing preference for a decentralized healthcare system are expected to drive market growth.


Point-Of-Care Diagnostics Market Key Developments:

In December 2021, Color Health and Thermo Fisher Scientific cooperated to offer Texas schools a k-12 readycheckgo covid-19 testing solution.

Global Point Of Care Diagnostics Market Summary

Study Period

2023-29

Base Year

2022

CAGR

11.9%

Largest Market

North America

Fastest Growing Market

Europe
Point Of Care Diagnostics Market Dynamics

Market Development for Point-of-Care Diagnostics The growing prevalence of chronic and infectious diseases in developing economies is a trend. Chronic diseases such as rheumatism, diabetes, and cancer are becoming more common worldwide for various reasons, including a rising geriatric population, sedentary lifestyles, unhealthy eating habits, and environmental factors. Chronic diseases, for example, kill almost 38 million people worldwide. Cardiovascular illnesses account for most of the chronic disease mortality (17.5 million persons per year), followed by malignancies (8.2 million), respiratory disorders (4 million), and diabetes (1.5 million). The diseases listed above account for 82% of all chronic condition deaths. Point-of-care diagnostics is gaining popularity among patients worldwide since samples are taken from the patient's site for testing, and findings may be obtained concisely because of micro fluids, chips, and nano diagnostics.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Point Of Care Diagnostics Market Segmentation

By Product Type
  • Infectious Disease Testing Kits
  • Cancer/Tumour Markers Testing
  • Cardio-Metabolic Monitoring Kits
  • Fertility and Pregnancy Testing Kits
  • Haematological Testing Kits
  • Faecal Occult Testing Kits
  • Glucose Monitoring Kits
  • Cholesterol Test Strips
  • Urinalysis Testing Kits
  • Others
By Prescription Mode
  • Over-the-counter (OTC) Testing Kits
  • Prescription-based Testing Kits
By End User
  • Hospitals
  • Diagnostic Centres
  • Homecare
  • Others

Frequently Asked Questions

The Glucose Monitoring Kits segment is set to lead the market by product.

The growing incidence of chronic and infectious diseases and inclination toward a decentralized health care system is anticipated to drive market growth.

Siemens-Healthineers, Abbott Laboratories, Inc., Quidel Corporation, Becton, Dickinson, and Company, bioMérieux, Roche Diagnostics, Life Scan IP Holdings, LLC, and Beckman Coulter, Inc. are the key players in the global point–of–care diagnostic market.

North America is anticipated to hold the highest market share in the market.

1. Executive summary
2. Global Point-of-Care Diagnostics Market Introduction
2.1. Global Point-of-Care Diagnostics  Market – Taxonomy
2.2. Global Point-of-Care Diagnostics  Market –Definitions
2.2.1. Product Type
2.2.2. Prescription Mode
2.2.3. End-User
3. Global Point-of-Care Diagnostics  Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Point-of-Care Diagnostics  Market Dynamics – Factors Impact Analysis
3.6. Global Point-of-Care Diagnostics  Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.6.3. Japan
3.7. Global Point-of-Care Diagnostics  Market – Recent Product Innovations
4. Global Point-of-Care Diagnostics  Market Analysis, 2017-2021 and Forecast 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Point-of-Care Diagnostics  Market, By Product Type, 2017-2021 and Forecast 2022-2028
5.1. Infectious Disease Testing Kits
5.1.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Cancer/Tumor Markers Testing
5.2.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Cardio-Metabolic Monitoring Kits
5.3.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Fertility and Pregnancy Testing Kits
5.4.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Hematological Testing Kits
5.5.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Fecal Occult Testing Kits
5.6.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Glucose Monitoring Kits
5.7.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Cholesterol Test Strips
5.8.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Urinalysis Testing Kits
5.9.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
5.10. Others
5.10.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
5.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.10.3. Market Opportunity Analysis
6. Global Point-of-Care Diagnostics  Market, By Prescription Mode, 2017-2021 and Forecast 2022-2028
6.1. Over-the-Counter (OTC) Testing Kits
6.1.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Prescription Based Testing Kits
6.2.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Point-of-Care Diagnostics  Market Forecast, By End-User, 2017-2021 and Forecast 2022-2028
7.1. Hospitals
7.1.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Diagnostic Centers
7.2.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Homecare
7.3.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Point-of-Care Diagnostics  Market Forecast, By Region, 2017-2021 and Forecast 2022-2028
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Point-of-Care Diagnostics  Market - Opportunity Analysis Index, By Product Type, Prescription Mode,  End-User, and Region, 2022 & 2028
9. North America Point-of-Care Diagnostics  Market Analysis, 2017-2021 and Forecast 2022-2028
9.1. Product Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Infectious Disease Testing Kits
9.1.2. Cancer/Tumour Markers Testing
9.1.3. Cardio-Metabolic Monitoring Kits
9.1.4. Fertility and Pregnancy Testing Kits
9.1.5. Haematological Testing Kits
9.1.6. Faecal Occult Testing Kits
9.1.7. Glucose Monitoring Kits
9.1.8. Cholesterol Test Strips
9.1.9. Urinalysis Testing Kits
9.1.10. Others
9.2. Prescription Mode Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Over-the-counter (OTC) Testing Kits
9.2.2. Prescription-based Testing Kits
9.3. End-User Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospitals
9.3.2. Diagnostic Centers
9.3.3. Homecare
9.3.4. Others
9.4. Country Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Point-of-Care Diagnostics  Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Country, 2022 & 2028
9.6. North America Point-of-Care Diagnostics  Market Dynamics – Trends
10. Europe Point-of-Care Diagnostics  Market Analysis, 2017-2021 and Forecast 2022-2028
10.1. Product Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Infectious Disease Testing Kits
10.1.2. Cancer/Tumor Markers Testing
10.1.3. Cardio-Metabolic Monitoring Kits
10.1.4. Fertility and Pregnancy Testing Kits
10.1.5. Hematological Testing Kits
10.1.6. Fecal Occult Testing Kits
10.1.7. Glucose Monitoring Kits
10.1.8. Cholesterol Test Strips
10.1.9. Urinalysis Testing Kits
10.1.10. Others
10.2. Prescription Mode Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Over-the-counter (OTC) Testing Kits
10.2.2. Prescription-based Testing Kits
10.3. End-User Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospitals
10.3.2. Diagnostic Centers
10.3.3. Homecare
10.3.4. Others
10.4. Country Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Point-of-Care Diagnostics  Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Country, 2022 & 2028
10.6. Europe Point-of-Care Diagnostics  Market Dynamics – Trends
11. Asia-Pacific Point-of-Care Diagnostics  Market Analysis, 2017-2021 and Forecast 2022-2028
11.1. Product Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Infectious Disease Testing Kits
11.1.2. Cancer/Tumor Markers Testing
11.1.3. Cardio-Metabolic Monitoring Kits
11.1.4. Fertility and Pregnancy Testing Kits
11.1.5. Hematological Testing Kits
11.1.6. Fecal Occult Testing Kits
11.1.7. Glucose Monitoring Kits
11.1.8. Cholesterol Test Strips
11.1.9. Urinalysis Testing Kits
11.1.10. Others
11.2. Prescription Mode Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Over-the-counter (OTC) Testing Kits
11.2.2. Prescription-based Testing Kits
11.3. End-User Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospitals
11.3.2. Diagnostic Centers
11.3.3. Homecare
11.3.4. Others
11.4. Country Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Point-of-Care Diagnostics  Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Country, 2022 & 2028
11.6. Asia Pacific Point-of-Care Diagnostics  Market Dynamics – Trends
12. Latin America Point-of-Care Diagnostics  Market Analysis, 2017-2021 and Forecast 2022-2028
12.1. Product Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Infectious Disease Testing Kits
12.1.2. Cancer/Tumor Markers Testing
12.1.3. Cardio-Metabolic Monitoring Kits
12.1.4. Fertility and Pregnancy Testing Kits
12.1.5. Hematological Testing Kits
12.1.6. Fecal Occult Testing Kits
12.1.7. Glucose Monitoring Kits
12.1.8. Cholesterol Test Strips
12.1.9. Urinalysis Testing Kits
12.1.10. Others
12.2. Prescription Mode Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Over-the-counter (OTC) Testing Kits
12.2.2. Prescription-based Testing Kits
12.3. End-User Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospitals
12.3.2. Diagnostic Centers
12.3.3. Homecare
12.3.4. Others
12.4. Country Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Point-of-Care Diagnostics  Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Country, 2022 & 2028
12.6. Latin America Point-of-Care Diagnostics  Market Dynamics – Trends
13. Middle East and Africa Point-of-Care Diagnostics  Market Analysis, 2017-2021 and Forecast 2022-2028
13.1. Product Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Infectious Disease Testing Kits
13.1.2. Cancer/Tumor Markers Testing
13.1.3. Cardio-Metabolic Monitoring Kits
13.1.4. Fertility and Pregnancy Testing Kits
13.1.5. Hematological Testing Kits
13.1.6. Fecal Occult Testing Kits
13.1.7. Glucose Monitoring Kits
13.1.8. Cholesterol Test Strips
13.1.9. Urinalysis Testing Kits
13.1.10. Others
13.2. Prescription Mode Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Over-the-counter (OTC) Testing Kits
13.2.2. Prescription-based Testing Kits
13.3. End-User Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospitals
13.3.2. Diagnostic Centers
13.3.3. Homecare
13.3.4. Others
13.4. Country Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Point-of-Care Diagnostics  Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Country, 2022 & 2028
13.6. MEA Point-of-Care Diagnostics  Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Siemens-Healthineers
14.2.2. Abbott Laboratories, Inc. (U.S.)
14.2.3. Koninklijke Philips N.V. (Netherlands)
14.2.4. Becton, Dickinson, and Company (U.S.)
14.2.5. Mologic Ltd (U.K.)
14.2.6. Roche Diagnostics (U.S.)
14.2.7. Nova Biomedical (U.S.)
14.2.8. Beckman Coulter, Inc. (U.S.)
14.2.9. Ngaio Diagnostics (New Zealand)
15. Research Methodology
16. Key Assumptions and Acronyms
  • Siemens AG
  • Abbott Laboratories
  • Koninklijke Philips N.V
  • Becton, Dickinson, and Company
  • Mologic Ltd
  • Johnson & Johnson Services
  • Sinocare
  • Roche Diagnostics
  • Nova Biomedical
  • Instrumentation Laboratory